2023
DOI: 10.3390/molecules28031174
|View full text |Cite
|
Sign up to set email alerts
|

3-Arylidene-2-oxindoles as Potent NRH:Quinone Oxidoreductase 2 Inhibitors

Abstract: The enzyme NRH:quinone oxidoreductase 2 (NQO2) plays an important role in the pathogenesis of various diseases such as neurodegenerative disorders, malaria, glaucoma, COVID-19 and cancer. NQO2 expression is known to be increased in some cancer cell lines. Since 3-arylidene-2-oxindoles are widely used in the design of new anticancer drugs, such as kinase inhibitors, it was interesting to study whether such structures have additional activity towards NQO2. Herein, we report the synthesis and study of 3-arylidene… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 38 publications
(52 reference statements)
0
2
0
Order By: Relevance
“…Studied 2-oxindole derivatives were obtained from the Department of Chemistry of Moscow State University. Synthesis and characterization data were described previously 16 , 24 , 25 .…”
Section: Methodsmentioning
confidence: 99%
“…Studied 2-oxindole derivatives were obtained from the Department of Chemistry of Moscow State University. Synthesis and characterization data were described previously 16 , 24 , 25 .…”
Section: Methodsmentioning
confidence: 99%
“…This is in strong contrast to the emerging evidence suggesting that plenty of known drugs interact with NQO2. In fact, the literature is full of examples of drugs and compounds that have been found to work as NQO2 inhibitors including imatinib and other ABL kinase inhibitors [105], imiquimod [106], chloroquine and hydroxychloroquine [107], imidazole derivatives and other cancer drug candidates [108][109][110][111]. Many drugs or their quinone metabolites are known NQO2 substrates such as mitomycin, tretazicar and other anti-cancer drugs [40], paracetamol, clozapine, carbamazepine and others [47].…”
Section: Conclusion and Future Perspectivesmentioning
confidence: 99%